Xephilio OCT-A1 receives 510(k) clearance

September 17, 2019
The FDA has granted 510(k) clearance to Canon U.S.A.’s Xephilio OCT-A1 OCT device, according to a press release. Together with the RX Capture…

New technologies aimed at practitioner acceptance

September 15, 2019
PARIS — Technology has a purpose at Carl Zeiss Meditec and that is to function as a vehicle, not the driver, for delivering efficiency and…

Alimera expands Iluvien distribution agreement with Horus

September 12, 2019
Alimera Sciences and Horus Pharma have expanded a distribution agreement to allow Horus to introduce Iluvien for diabetic macular edema and…

Wize Pharma licenses Copernicus’ gene therapy technology

September 10, 2019
Wize Pharma has entered into an exclusive license agreement to develop and commercialize products based on non-viral gene therapy technology from…

Keranova completes 24 million euro funding round

September 10, 2019
Keranova has raised 24 million euros in a second round of financing to support development of its automated robotized procedures for cataract…

Zeiss launches Cirrus 6000 OCT

September 10, 2019
Zeiss has launched the Cirrus 6000 100 kHz ultra-fast OCT system, according to a press release. The new addition to the Zeiss OCT device portfolio…

Advancing Eyecare acquires Ophthalmic Instruments Inc.

September 9, 2019
Advancing Eyecare has acquired the ophthalmic instrument distributor Ophthalmic Instruments Inc., according to a press release. Advancing Eyecare, a…

Santen microshunt study results lead news of the week

September 7, 2019
Here are some of the past week’s top stories on Healio.com/OSN:

Sight Sciences financing to support Omni, TearCare systems

September 6, 2019
Sight Sciences has closed $31 million in Series D preferred stock financing in order to accelerate the growth of its Omni surgical system and…

iSTAR Medical completes Series C funding round

September 6, 2019
iSTAR Medical has completed 40 million euros in Series C financing to be used in the development of its MINIject device for the treatment of…

Regenxbio, Clearside enter option and license agreement for SCS Microinjector

September 6, 2019
Regenxbio and Clearside Biomedical announced an option and license agreement that will give Regenxbio exclusive worldwide rights to Clearside’s…

NHS England to fund Luxturna treatment

September 5, 2019
NHS England will fund Luxturna gene therapy treatment for inherited retinal dystrophies starting in January 2020, according to a press release…

Aerpio posts $5.7 million net loss in second quarter

September 5, 2019
Aerpio Pharmaceuticals reported a second quarter net loss of $5.7 million, or $0.14 per share, compared with a net loss of $6 million, or $0.22 per…

AmEx recalls all lots of bevacizumab

September 4, 2019
All lots of bevacizumab 1.25 mg/0.05 mL 31-gauge injectable and bevacizumab 2.5 mg/0.1 mL Normject TB injectable from Pacifico National, doing…

NovaBay net loss increases in second quarter

September 3, 2019
NovaBay Pharmaceuticals reported a second quarter net loss of $2.5 million, or $0.14 per share, compared with a net loss of $1.6 million, or $0.09…

Harrow Health revenue increases in second quarter

August 30, 2019
Harrow Health reported total revenues of $13.5 million in the second quarter of 2019 compared with $10.4 million in the same period a year ago…

Topcon launches Maestro2 OCT system

August 29, 2019
Topcon has launched the Maestro2 automated OCT/fundus camera with OCT angiography, according to a press release. A fully automated OCT system, the…

EyeGate records no revenue in second quarter

August 29, 2019
EyeGate Pharmaceuticals reported it did not recognize any revenue for the second quarter of 2019, according to a press release. In 2018 and the first…

Medeuronet acquires IROC Science’s clinical studies business

August 28, 2019
Switzerland-based IROC Science’s clinical study business assets have been acquired by the medical device consulting firm Medeuronet, according…

Alimera posts $5 million quarterly net loss

August 27, 2019
Alimera Sciences reported a second quarter net loss of $5 million compared with a net loss of $4 million in the second quarter of 2018, according to…